The M Health Fairview Center has been a world leader in treating hematologic malignancies with blood and marrow transplant (BMT) since 1968, when the world’s first successful BMT for a cancer patient was performed here.
Cancers of blood cells develop in the blood, bone marrow, or lymph nodes. Blood cancers can lead to low numbers of or poorly functioning white blood cells, red blood cells, and platelets. Patients can present with fatigue, bruising or bleeding, infections, weight loss, and night sweats.
Our approach
M Health Fairview Cancer Care is known for its innovative and groundbreaking care for patients with blood cancers. Many treatments that are now available to patients around the world were pioneered at our National Cancer Institute-designated Comprehensive Cancer Center: Masonic Cancer Center, University of Minnesota.
We have been a world leader in treating hematologic malignancies with blood and marrow transplant (BMT) since 1968, when the world’s first successful BMT for a cancer patient was performed here. Since then, our physicians have performed roughly 6,000 transplants for patients with leukemia, lymphoma, myeloma, and other blood cancers.
Our care team creates individualized treatment plans for patients with cancers of the blood by evaluating not only the type and severity of the disease, but also the patient’s overall health and goals for treatment.
We continue to perform leading-edge research, including the use of cellular therapy to motivate the body’s own “natural killer” cells to destroy cancer cells. This research, conducted in collaboration with scientists at the Masonic Cancer Center, benefits patients who have not responded to standard therapies.
Providers for Blood Cancers (Hematologic Malignancies)
